Therefore, characterising of the proline oxidase expression in endometrial cancer seems to be important since it is possible to maintain high expression of proline oxidase despite mutation in TP53. Finally, our study indicates induction of prolidase activity as an approach for proline oxidase-dependent apoptosis. This evidence concerns the gene TP53 and endometrial cancer.